VistaGen Therapeutics, Inc.
VTGN · NASDAQ
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Market Cap | $127 | $64 | $77 | $91 |
| - Cash | $63 | $49 | $67 | $75 |
| + Debt | $1 | $2 | $2 | $2 |
| Enterprise Value | $65 | $17 | $11 | $18 |
| Revenue | $0 | $0 | -$0 | $0 |
| % Growth | 5.7% | 1,726.7% | -106.4% | – |
| Gross Profit | $0 | $0 | -$0 | $0 |
| % Margin | 100% | 30.7% | 100% | 100% |
| EBITDA | -$19 | -$15 | -$14 | -$15 |
| % Margin | -7,454.3% | -6,117.2% | 95,526.7% | -6,392.7% |
| Net Income | -$19 | -$15 | -$14 | -$14 |
| % Margin | -7,526% | -6,186.5% | 90,900% | -6,020.9% |
| EPS Diluted | -0.54 | -0.47 | -0.44 | -0.46 |
| % Growth | -14.9% | -6.8% | 4.3% | – |
| Operating Cash Flow | -$14 | -$19 | -$10 | -$10 |
| Capital Expenditures | -$0 | $0 | -$0 | $0 |
| Free Cash Flow | -$14 | -$19 | -$10 | -$10 |